NSE filing, NSE: GLOTTIS. Summary written from the filing by ALFA Finder's alert engine.
Glottis Ltd: key numbers
- Share price
- ₹59.90
- Market cap
- ₹553.5 Cr
- Revenue (annual)
- ₹722.6 Cr
- Net profit (annual)
- ₹37.72 Cr
- P/E (TTM)
- 15.2×Sector 32.4×
- Promoter holding
- 74.23%+0.00% QoQ
- FII holding
- 0.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Glottis Ltd
All →Glottis Debt & Borrowing: ₹60 Cr
Glottis's board approved up to ₹60 Crore of interest-free unsecured loans from two Managing Directors. The related-party loans fund working capital and are not at arm's length.
- Value
- ₹60.00 Cr
- Execution
- Up to 5 years from each tranche disbursement
Glottis Debt & Borrowing: ₹4.65 Cr
Glottis revised its unsecured inter-corporate loan to wholly owned subsidiary Glottis Inc., now up to US$5 lakh. The interest rate moved to highest borrowing cost plus 0.50% spread.
- Value
- ₹4.65 Cr
- Execution
- Repayable within five years from initial disbursement under the July 03, 2026 loan agreement
Glottis Q2 FY27 Results: Net Profit ₹0.2 Cr, Down 98.4% YoY
Glottis Ltd reported revenue from operations of ₹276.5 Cr (+28.8% YoY) and net profit of ₹0.2 Cr (-98.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.2 Cr · -98.4% YoY
Glottis Capacity Expansion
Glottis Limited has opened a new branch office in Hyderabad, Telangana, effective November 05, 2026. This expansion aims to enhance the company's operational reach and regional customer service.
- new branches
- 1.0 branches
Glottis Annual General Meeting
Glottis Limited concluded its 4th Annual General Meeting on September 28, 2026. Shareholders approved the financial statements and the re-appointment of a Director.
Glottis Merger & Restructuring
Glottis Limited has incorporated a wholly-owned subsidiary, Glottis Logistics SDN. BHD., in Malaysia. This strategic move aims to expand the company's footprint in freight forwarding.
Other other announcement announcements
All →Bal Pharma Other Announcement
Bal Pharma filed a Reg 32 statement confirming no deviation in its ₹2.10 Cr preferential warrant proceeds, with nothing utilised by September 30, 2026. The amount remains fully unutilised.
- Value
- ₹2.10 Cr
Lenskart Solutions Other Announcement
Lenskart filed a Reg 32 monitoring agency report on IPO proceeds for the quarter ended September 2026. Utilisation matches the prospectus with no deviations.
TGV SRAAC Other Announcement
TGV Sraac's board noted a CIN change, registered by MCA on 27 October 2026. It followed an objects clause alteration approved at the September 2026 AGM.
Manaksia Coated Metals & Industries Other Announcement
Manaksia Coated Metals filed its quarterly shareholding pattern, with promoters holding 51.93%. The filing is routine regulatory disclosure with no transaction or corporate event.
Network People Services Technologies Other Announcement
Network People Services Technologies reported a Reg 32 statement confirming no deviation in use of its Rs 300 Crore preferential allotment proceeds. Rs 56.52 Crore utilised by September 30, 2026, with the Audit Committee reviewing it.
Tata Power Company Other Announcement
Tata Power's auditor SRBC & Co issued a limited-assurance report confirming compliance with debenture trust deed covenants as at September 30, 2026. It is a routine Reg 56(1)(d) compliance certificate with no new money or business event.